98 related articles for article (PubMed ID: 26854966)
1. A novel ATM-dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in melanoma.
Spoerri L; Brooks K; Chia K; Grossman G; Ellis JJ; Dahmer-Heath M; Škalamera D; Pavey S; Burmeister B; Gabrielli B
Pigment Cell Melanoma Res; 2016 May; 29(3):329-39. PubMed ID: 26854966
[TBL] [Abstract][Full Text] [Related]
2. ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.
Jaiswal H; Benada J; Müllers E; Akopyan K; Burdova K; Koolmeister T; Helleday T; Medema RH; Macurek L; Lindqvist A
EMBO J; 2017 Jul; 36(14):2161-2176. PubMed ID: 28607002
[TBL] [Abstract][Full Text] [Related]
3. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.
Kaufmann WK; Nevis KR; Qu P; Ibrahim JG; Zhou T; Zhou Y; Simpson DA; Helms-Deaton J; Cordeiro-Stone M; Moore DT; Thomas NE; Hao H; Liu Z; Shields JM; Scott GA; Sharpless NE
J Invest Dermatol; 2008 Jan; 128(1):175-87. PubMed ID: 17597816
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.
Li Z; Liu J; Li J; Kong Y; Sandusky G; Rao X; Liu Y; Wan J; Liu X
J Biol Chem; 2017 Oct; 292(42):17461-17472. PubMed ID: 28900036
[TBL] [Abstract][Full Text] [Related]
6. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
7. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.
Xu B; Kim ST; Lim DS; Kastan MB
Mol Cell Biol; 2002 Feb; 22(4):1049-59. PubMed ID: 11809797
[TBL] [Abstract][Full Text] [Related]
8. The mismatch repair system is required for S-phase checkpoint activation.
Brown KD; Rathi A; Kamath R; Beardsley DI; Zhan Q; Mannino JL; Baskaran R
Nat Genet; 2003 Jan; 33(1):80-4. PubMed ID: 12447371
[TBL] [Abstract][Full Text] [Related]
9. Increased oxidative stress in AOA3 cells disturbs ATM-dependent DNA damage responses.
Kobayashi J; Saito Y; Okui M; Miwa N; Komatsu K
Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():42-50. PubMed ID: 25868131
[TBL] [Abstract][Full Text] [Related]
10. Defective decatenation checkpoint function is a common feature of melanoma.
Brooks K; Chia KM; Spoerri L; Mukhopadhyay P; Wigan M; Stark M; Pavey S; Gabrielli B
J Invest Dermatol; 2014 Jan; 134(1):150-158. PubMed ID: 23842115
[TBL] [Abstract][Full Text] [Related]
11. Regulation of polo-like kinase 1 by DNA damage and PP2A/B55α.
Wang L; Guo Q; Fisher LA; Liu D; Peng A
Cell Cycle; 2015; 14(1):157-66. PubMed ID: 25483054
[TBL] [Abstract][Full Text] [Related]
12. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
[TBL] [Abstract][Full Text] [Related]
13. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
14. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
15. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
[TBL] [Abstract][Full Text] [Related]
16. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
17. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest.
Girard PM; Riballo E; Begg AC; Waugh A; Jeggo PA
Oncogene; 2002 Jun; 21(27):4191-9. PubMed ID: 12082606
[TBL] [Abstract][Full Text] [Related]
18. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
[TBL] [Abstract][Full Text] [Related]
19. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
20. Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM-Chk1/2-Cdc25C pathway.
Ma YC; Su N; Shi XJ; Zhao W; Ke Y; Zi X; Zhao NM; Qin YH; Zhao HW; Liu HM
Toxicol Appl Pharmacol; 2015 Jan; 282(2):227-36. PubMed ID: 25450480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]